Equine hyperadrenocorticism: A report of 4 natural cases

PDF (English)
Publiée : Dec 6, 2017
DOI : https://doi.org/10.12681/jhvms.15149
C. K. KOUTINAS (X.K. ΚΟΥΤΙΝΑΣ)
Clinic of Companion Animal Medicine, School of Veterinary Medicine, A.U.T.
M. N. SARIDOMICHELAKIS (Μ.Ν. ΣΑΡΙΔΟΜΙΧΕΛΑΚΗΣ)
Clinic of Companion Animal Medicine, School of Veterinary Medicine, A.U.T.
M. E. MYLONAKIS (Μ.Ε. ΜΥΛΩΝΑΚΗΣ)
Clinic of Companion Animal Medicine, School of Veterinary Medicine, A.U.T., Greece
K. HAMHOUGIAS (Κ. ΧΑΜΧΟΥΓΙΑΣ)
Veterinarian
A. FYTIANOU (Α. ΦΥΤΙΑΝΟΥ)
Laboratory of Clinical Diagnosis and Clinical Pathology, School of Veterinary Medicine, A.U.T.
N. DIAKAKIS (Ν. ΔΙΑΚΑΚΗΣ)
Clinic of Surgery, School of Veterinary Medicine, A.U.T.
A. F. KOUTINAS (Α.Φ. ΚΟΥΤΙΝΑΣ)
Résumé

Hyperadrenocorticism, the most common equine endocrinopathy, is the result of hyperplasia or a functional adenoma of the pars intermedia (intermediate lobe) of the pituitary gland. The study population included a 20-year old Irish hunting gelding (case 1), a 13-year old English Thoroughbred stud horse (case 2), an 18-year old intact male donkey (case 3) and a 22-year old mare belonging to a mixed breed (case 4). From a historical and clinical standpoint, the most common clinical signs were hypertrichosis (4/4), progressive loss of body weight (3/4), polyuria-polydipsia (3/4), laminitis (3/4), depression-lethargy (2/4), sway-back (lordosis) (2/4), pot-belly (2/4), bulging of the supraorbital region due to the excessive deposition of adipose tissue (2/4), hyperhidrosis (2/4) and delayed wound healing (2/4). The results of the routine laboratory testing showed lymphopenia (4/4), anemia (2/4), mature neutrophilia (1/4), monocytosis (1/4), hypertriglyceridemia (4/4), increased ALP activity (3/4), hypocalcemia (3/4) and hypoalbuminemia (2/4). Also, case 2 developed type III diabetes mellitus as a consequence of the disease. The diagnosis of hyperadrenocorticism, that was initially based on the classical clinical signs, noticed in all 4 animals, was further confirmed in 3 of them (cases 1, 3, 4) with the overnight dexamethasone suppression test. Oral bromocryptine (dopamine agonist), that was subsequently prescribed in two horses (cases 1, 4) resulted in a remarkable clinical improvement, first noticed in both animals approximately two months after the beginning of the treatment.

Article Details
  • Rubrique
  • Research Articles

Authors who publish with this journal agree to the following terms:

· Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

· Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

· Authors are permitted and encouraged to post their work online (preferably in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Téléchargements
Les données relatives au téléchargement ne sont pas encore disponibles.
Références
Allen JR, Crisman MV, Barbee DD (1988) Diagnosis of equine pituitary tumors by computed tomography-Part II. Compend ContEducPract Vet, 10:1196-1200.
Auer DE, Wilson RG, Groenendijk S, Filippich LJ (1987) Glucose metabolism in a pony mare with a tumour of the pituitary gland pars intermedia. Aust Vet J, 64: 379-382.
Beech J (1987) Tumors of the pituitary gland (pars intermedia). In: Current Therapy in Equine Medicine II. WB Saunders, Philadelphia,: 182-185.
Beech J (1994) Treatment of hypophysial adenomas. Compend ContEduc 16: 921-923.
Boujon CE, Bestetti GE, Meier HP, Straub R, Junker U, Rossi GL (1993) Equine pituitary adenoma, a functional and morphological study. J Comp Pathol, 109:163-178.
Colahan PT (1991) Diseases of the pituitary gland. In: Equine Medicine and Surgery. 4th ed, American Veterinary Publications, Goleta,: 1740-1745.
Couetil L (1996) New developments in equine Cushing's disease. Equine Pract, 18:28-37.
Deem DA, Whitlock RH (1982) The pituitary gland. In: Equine Medicine and Surgery II. American Veterinary Publications, Santa Barbara,: 885-890.
Dybdal NO, Hargreaves KM, Madigan JE, Gribble DH, Kennedy PC, Stabenfeldt GH (1994) Diagnostic testing for pituitary pars intermedia dysfunction in horses. J Am Vet Med Assoc, 204: 627-632.
Dybdal Ν (1997) Pituitary pars intermedia dysfunction (equine Cushing's - like disease). In: Current Therapy in Equine Medicine. 4th ed. WB Saunders, Philadelphia,: 499 - 501.
Evans LH, Siegel ET, Hubben Κ (1968) Clinico-pathologic Conference. J Am Vet Med Assoc 152:1778-1786.
Field JR, Wolf C (1988) Cushing's syndrome in a horse. Equine Vet J, 20: 301-304.
Fix AS, Miller LD (1987) Equine adrenocortical carcinoma with hypercalcemia. Vet Pathol 1987,24:190-192.
Freestone JT, Melrose PA (1995) Hyperadrenocorticism. In: The Horse: Diseases and Clinical Management. WB Saunders, Philadelphia,: 1145-1148.
Garner HE, Hahn AW, Salem C, Coffman JR, Hutcheson DP, Johnson JH (1977) Cardiac output, left ventricular ejection rate and heart rate changes in equine laminitis hypertension. Am J Vet Res, 38: 725-729.
Harkema JR, Robinson NE, Scott JB (1978) Cardiovascular, acid-base, electrolyte and plasma volume changes in ponies developing alimentary laminitis. Am J Vet Res, 39: 741-744.
Heinrichs M, Baumgartner W, Capen CC (1990) Immunocytochemical demonstration of proopiomelanocortin – derived peptides in pituitary adenomas of the pars intermedia on horses.
Vet Pathol, 17: 419-425.
Hillyer MH, Taylor FGR, Mair TS, Murphy D, Watson TDG, Love S (1992) Diagnosis of hyperadrenocorticism in the horse. Equine Vet Educ, 4:131 - 134.
Hood DM (1999) Laminitis as a systemic disease. Vet Clin North Am Equine Pract 15: 481-494.
Levy M, Sojka JE, Dybdal NO (1999) Diagnosis and treatment of equine Cushing's disease. Compend Cont Educ 21: 766-769
Lloyd DH, Littlewood JD, Craig JM, Thomsett LR (2003) Cushing's disease. In: Practical Equine Dermatology. Blackwell Publishing UK,: 105-108.
Loeb WF, Capen CC, Johnson LE (1966) Adenomas of the pars intermedia associated with hyperglycemia and glycosuria in two horses. Cornell Vet, 56: 623 - 626.
Love S (1993) Equine Cushing's disease. Br Vet J, 149:139-153.
Orth DN, Holscher MA, Wilson MG, Nicholson WE, Plue RE, Mount CD (1982) Equine Cushing's disease, plasma immunoreactive proopiolipomelanocortin peptide and cortisole levels
basally and in response to diagnostic tests. Endocrinology, 110:1430-1441,
Pallaske G (1932) Zur kasuistik seltnere Geschwulste bei den Haustieren. Ζ Krebsforsch, 36: 342.
Paradis MR, Hines MT (2002) Endocrinology. In: Equine Medicine Secrets. Hanley and Belfus, Philadelphia,: 47-64.
Raker CW, Fegley H (1965) Clinico-pathologic conference. J Am Vet Med Assoc, 147: 848-860.
Reed SM (1998) Pituitary adenomas: equine Cushing's disease. In: Equine Internal Medicine. WB Saunders, Philadelphia,: 912 -916.
Rivas L (1998) Endocrine pancreas. In: Equine Internal Medicine. WB Saunders, Philadelphia,: 936-937.
Scott DW (1988) Equine hyperadrenocorticism. In: Large Animal Dermatology. WB Saunders, Philadelphia,: 378-381.
Scott DW, Miller WH Jr (2003) Endocrine disorders. In: Equine Dermatology. WB Saunders, Philadelphia,: 548 - 559.
Staemphli HR, Eigenmann EJ, Clarke LM (1988) Insulin treatment and development of anti-insulin antibodies in a horse with diabetes mellitus associated with a functional pituitary adenoma. Can Vet J, 29: 934-936.
van der Kolk JH, Kalsbeek HC, van Garderen E, Wensing Τ, Breukink Η J (1993) Equine pituitary neoplasia: a clinical report of 21 cases (1990 -1992). Vet Ree, 133:594-597.
van der Kolk JH, Mars MH, van der Gaag I (1994) Adrenocortical carcinoma in a 12-year old mare. Vet Ree, 134:113-115.
van der Kolk JH (1995) Diagnosis of equine hyperadrenocorticism. Equine Pract, 17: 24-27.
van der Kolk (1997) Equine Cushing's disease. Equine Vet Educ, 9:209-214.
van der Kolk JH (1998) Diseases of the pituitary gland, including hyperadrenocorticism. In: Metabolic and Endocrine Problems of the Horse. WB Saunders, Philadelphia,: 41-59.
van der Kolk JH, Ijzer J, Overgaauw PAM, van der Linde-Sipman JS (2001) Pituitary - independent Cushing's syndrome in a horse. Equine Vet J, 33:110-112.
Wilson MG, Nicholson WE, Holscher MA, Sherrell BJ, Mount CD, Orth DN (1982) Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor and plasma of normal and
Cushing's horses. Endocrinology, 110: 941 - 954.
Articles les plus lus par le même auteur ou la même autrice